002550.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 03:04):

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China...

Stats
Today's Volume	8.23M
Average Volume	11.98M
Market Cap	5.95B
EPS	CNY0.0618 ( 2023-10-24 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	24.58
ATR14	CNY0.00900 (0.19%)

Volume Correlation

Long: 0.08 (neutral)

Short: 0.39 (neutral)

Signal:(47.642) Neutral

Changzhou Qianhong Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Changzhou Qianhong Correlation - Currency/Commodity

0.49
( neutral )

0.14
( neutral )

0.00
( neutral )

0.69
( moderate )

Changzhou Qianhong Financials

Annual	2022
Revenue:	CNY2.30B
Gross Profit:	CNY888.97M (38.59 %)
EPS:	CNY0.250

Q3	2023
Revenue:	CNY409.19M
Gross Profit:	CNY187.61M (45.85 %)
EPS:	CNY0.0618

Q2	2023
Revenue:	CNY448.54M
Gross Profit:	CNY203.07M (45.27 %)
EPS:	CNY0.0259

Q1	2023
Revenue:	CNY608.22M
Gross Profit:	CNY238.72M (39.25 %)
EPS:	CNY0.0672

Financial Reports:

No articles found.

Changzhou Qianhong

Changzhou Qianhong Biopharma CO.,LTD engages in the research and development, production, and sale of bio-pharmaceutical products with a focus on polysaccharides and enzymes in China. The company provides various API products, including heparin sodium, heparin calcium, enoxaparin sodium, nadroparin calcium, and dalteparin sodium for use as anticoagulants; pancreatin for use as a digestive agent; asparaginase for use as an antineoplastic agent; kallidinogenase kallikrein for use in the treatment of microcirculation disorders; and heparinoid. It also offers a range of preparations, such as nadroparin calcium PFS, enoxaparin sodium PFS, dalteparin sodium PFS, and asparaginase and heparin sodium injections for use as anticoagulants. In addition, the company exports its products. Changzhou Qianhong Biopharma CO.,LTD was founded in 1971 and is headquartered in Changzhou, China.